REQUEST A DEMO
Total
USD $0.00
Search more companies

A N Pharmaceuticals Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: A N Pharmaceuticals Private Limited Profile Updated: November 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

A N Pharmaceuticals Private Limited is an unlisted company, incorporated on 22/11/2000. It has its registered office in the State of Delhi, India. Company's corporate identification number (CIN) is U24233DL2000PTC108617 and registration number is 108617. The company is a trade company, it is engaged in wholesale trading.

Headquarters
F-1/4 Okhla Industrial Area Phase-I New Delhi In 110020
South Delhi; Delhi; Postal Code: 110020

Contact Details: Purchase the A N Pharmaceuticals Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the A N Pharmaceuticals Private Limited report to view the information.
Outstanding Shares:
Purchase the A N Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the A N Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
November 22, 2000
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
69.58%
Purchase this report to view the information.
4.55%
Company Performance
Financial values in the chart are available after A N Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-13.85%
Total operating revenue
-13.8%
Operating profit (EBIT)
21.84%
EBITDA
8.2%
Net Profit (Loss) for the Period
26.1%
Total assets
8.56%
Total equity
13.15%
Operating Profit Margin (ROS)
1.67%
Net Profit Margin
1.34%
Return on Equity (ROE)
1.2%
Debt to Equity Ratio
60.9%
Quick Ratio
0.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?